Skip To Main Content
Adam May SA on Muck Rack

Adam May SA

As seen in: PeerJ
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Adam May

Contact Adam May, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Identification of the RRM1 gene family in rice (Oryza sativa) and its response to rice blast

|
By Adam May SA, Lee HS, Lee DK, Kim Ys
| PeerJ
Rice genome sequence, annotation, protein sequence, and gene structure files were downloaded from the Ensembl Plants database (http://plants.ensembl.org/index.html). The HMM (Hidden Markov Model) PF00076.24 (RRM1 domain) of the RRM1 gene family was downloaded from the Pfam database (http://pfam.xfam.org/). We used HMMER3.2 software to search and analyze the database and predict the RRM1 gene family in rice, obtaining an E-value < 1 × 10−5.
Open in Who Shared Issue with article?

Jounce Therapeutics: An Undervalued Biotech Flush With Big Pharma Cash

|
By Adam May SA
| citybizlist.com
Summary Jounce therapeutics is a differentiated player in the hot immuno-oncology sector. JNCE stock has not been fairly priced after its newly struck partnership with Gilead Sciences, making it a compelling buy for the short term. JNCE's drug discovery engine continues to impress, potentially making it an equally compelling pick for the longer term. Jounce Therapeutics (JNCE) is a small biotechnology company focused on the rapidly expanding industry of immuno-oncology.
Open in Who Shared Issue with article?
See all 2 articles